**Question:** Toxicity of Oral Xa inhibitors are treated by

A. Vitamin K
B. Fresh frozen plasma
C. Heparin
D. Direct Thrombin Inhibitors (e.g., Argatroban)

**Correct Answer:** A. Vitamin K

**Core Concept:**
Oral Xa inhibitors are a class of anticoagulants that work by inhibiting the activity of the enzyme Xa (Xa inhibitors: Apixaban, Rivaroxaban, and Edoxaban). These medications are used to prevent and treat different thromboembolic conditions, but their toxicity may arise due to overdose or other adverse events.

**Why the Correct Answer is Right:**
Toxicity of oral Xa inhibitors primarily results from impaired anticoagulant function, which may lead to increased bleeding. Vitamin K is a crucial nutrient required for the synthesis of coagulation factors II, VII, IX, X, protein C, and protein S. Vitamin K is a cofactor for gamma-carboxylation, which is a post-translational modification that activates these proteins.

**Why Each Wrong Option is Incorrect:**

A. Fresh frozen plasma (FFP) contains clotting factors, but it does not specifically address the issue of impaired Xa inhibitors' function. Additionally, providing FFP may lead to an increased risk of bleeding due to excessive clotting factors.

B. Direct Thrombin Inhibitors (e.g., Argatroban) are another class of anticoagulants that target thrombin (another key enzyme in the coagulation cascade, but they are not specific for the treatment of Xa inhibitor toxicity.

C. Heparin is a broad-spectrum anticoagulant that works by inhibiting the activity of thrombin, but it is not specific to treat Xa inhibitors' toxicity.

**Clinical Pearl:**
In case of oral Xa inhibitor toxicity, using vitamin K supplementation is the appropriate management strategy as it specifically targets the impaired coagulation cascade without increasing the risk of bleeding due to excessive clotting factors.